ARCHIVES

In Brief: Smyth Moves From AOR To Bristol-Myers; Lurie Center Wins Grants From Army, NCI

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

In Brief: Robert Weinberg to Receive Bristol-Myers Award; Leffall Chosen for Poster Series

April 13, 1984

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976

October 31, 1975